Ascenion has supported the Helmholtz Zentrum München and iThera Medical GmbH in negotiating a cooperation agreement with ZEISS. The three partners will together develop an innovative microscope to enable scientists to look beneath the skin of living organisms. The technique exploits both the optical and acoustic properties of tissues. There are…
Project ideas for the 6th selection round may be submitted until 15 July 2013. The GO-Bio competition is a funding initiative of the German Federal Ministry of Education and Research (BMBF). It targets research teams in the life sciences interested in advancing technically demanding ideas into viable start-ups. Of the 39 projects supported to…
In February this year, Dr Torben Söker joined Ascenion’s team in Hanover as technology scout. Together with his colleague Dr Ralf Cordes, he will support scientists and technology transfer professionals at the Hannover Medical School (MHH).
Before he joined Ascenion, he did clinical research at the University Hospital Düsseldorf focusing on…
Seventeen experienced managers, investors and regulatory experts get together for two and a half days to coach and advise a maximum of 10 spin-off teams – in a concentrated but relaxed working atmosphere. You can take advantage of this opportunity at the Biotech NetWorkshop for life-sciences entrepreneurs, hosted annually by Ascenion and Max…
After more than a year’s successful cooperation with Ascenion, the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) has decided to become a co-founder of the LifeScience Foundation. The HZDR conducts research in the fields of energy, health and matter, gaining new insights that will help to maintain and improve the quality of human life. Cancer…
Leading genome researchers and distinguished international guests came together recently in Heidelberg for the 5th annual meeting of the Program of Medical Genome Research. During the three-day meeting they presented their latest research results and discussed the future of genome research in Germany. Also present was Dr Hubert Müller from…
In October 2012, Dr Stefanie Possekel joined Ascenion as Director Technology Management. Based in Munich, she will support Ascenion's management and team in the strategic development of client relationships and business areas, together with her colleagues Tina Damm, Dr Christian Wunsch (both Directors Technology Management) and Thieß Gert Matzke…
BioVaria brings together Europe’s top scientists and technology transfer professionals with potential licensees and investors from the international biopharmaceutical industry.
In just one, interactive day, it showcases around 50 licensable life-science technologies originating from publicly funded research as well as some of Europe’s most…
In our new issue you can find out what Professor Klaus Rajewsky has to say about new animal models for the MGC Foundation, what Professor Klaus Brandenburg thinks about technology transfer, and why the Baader Bank is investing for the first time in a life-science start-up. You can also read our News in brief and information on forthcoming…
Scientists from the German Center for Neurodegenerative Diseases (DZNE) and the Max Planck Research Unit for Enzymology and Protein Folding have developed a new approach to the treatment of multiple sclerosis. By chemically linking two approved pharmaceuticals – members of the cyclosporin und FK506 (tacrolimus) series – they have created a…
Twenty-one Leibniz Association institutes are to join a new interdisciplinary research network, combining their expertise in drug discovery and development. The Leibniz Association has launched the initiative in response to the changing requirements of society and the environment, with the goal of providing new active substances for use in…
The BNI, FZB and HPI have been working with Ascenion for more than six years now. Up to the beginning of 2012, the collaboration was co-funded by the German Federal Ministry of Education and Research, but from April 2012 the institutes have been financing their continued commitment to technology transfer from their own resources. ‘Technology…
End of August, the Association of University Technology Managers (AUTM) has released a summary of key figures on technology transfer in the US. Accordingly, the 186 institutions participating in the survey achieved USD 2.5 billion income from technology transfer, executed 4,899 licenses and formed 671 start-ups in the fiscal year 2011. The…
In June this year, two experienced professionals joined Ascenion as technology managers. Based in Berlin, they will collaborate closely with the Max Delbrück Centre for Molecular Medicine, Berlin-Buch, and the German Rheumatism Research Center Berlin.Dr Michael Karle has just returned from Gothenburg, where he worked for eight years with…
Dr Manfred Baier joined Ascenion’s Advisory Board on 1 June this year. The company thereby gains an experienced industry manager with special expertise in the development and marketing of innovative diagnostics. Further information:
www.ascenion.de/en/news/press-releases-2012/
21 June 2012, Munich – Dr Manfred Baier joined Ascenion’s Advisory Board on 1 June this year. The company thereby gains an experienced industry manager with special expertise in the development and marketing of innovative diagnostics. “We extend a warm welcome to Dr Baier,” said Dr Christian Stein, CEO of Ascenion. “His long-standing…
The TTS Europe is Europe’s original TTO to industry networking, discussion, debate and deal-making event for life sciences technology transfer, and is a limited size, high-level and interactive meeting in which all participants are actively involved in key discussions with approximately 150 other key participants from technology transfer,…
23 May 2012, Munich – Thirteen European technology transfer organizations and a guest partner from Canada were the joint organizers of BioVaria, which took place last week in Munich for the fifth year running. The feedback from organizers and participants alike was extremely positive: in the five years since Ascenion launched BioVaria, the…
